Results 91 to 100 of about 4,765 (219)
Clinical relevance of soluble HLA class I molecules in Waldenstrom Macroglobulinemia.
, 2008 International audienceOBJECTIVES: Waldenstrom Macroglobulinemia (WM) is a B-cell neoplasm characterised by secretion of IgM by lymphoplasmacytic bone marrow cells and by cytopenias and hypogammaglobulinemia in a subset of patients.
Yasmine Sebti +37 more
core +1 more source
, 1994 Monoclonal gammopathy is associated with both Waldenstrom\u27s Macroglobulinemia as well as Sjogren\u27s syndrome.
Sreedhar V. Potaraw; Thomas A. Aaberg; Norman J. Schatz; Joel S. Glaser
core
Hearing Loss in a Patient with Waldenstrom Macroglobulinemia Receiving Bortezomib
Introduction: We present a case report of hearing loss in a patient with Waldenstrom macroglobulinemia (WM) receiving treatment with bortezomib. Case Presentation: Our patient developed sudden bilateral sensorineural hearing loss after receiving three ...
Jack Fitzsimons +2 more
core +1 more source
Penyakit Waldenstrom Makroglobulinemia [PDF]
, 2015 Penyakit Waldenstrom Makroglobulinemia adalah kelainan limfoproliferatif sel B yang tidak umum, ditandai dengan infiltrasi sumsum tulang dan produksi immunoglobulin monoklonal IgM.
Wirawan, R. (Riadi) +1 more
core
Current and novel BTK inhibitors in Waldenstrom's macroglobulinemia
, 2021 The current therapeutic approach in Waldenstrom's macroglobulinemia (WM) is being driven by insights in disease biology and genomic landscape. Bruton's tyrosine kinase (BTK) plays a key role in signaling pathways for the survival of WM clone ...
Fotiou +4 more
core
Waldenstrom macroglobulinemia - indolent disorder or slow killer?
, 2020 Waldenström macroglobulinemia (WM) is an indolent (slow-growing) subtype of non-Hodgkin lymphoma that affects small lymphocytes. The risk of WM increases with age with median age at diagnosis of 63 years. Men are more likely than women to develop the WM.
Miličević, Ozana +5 more
core +1 more source
Case Reports in Neurology, 2013 Patients with anti-myelin-associated glycoprotein (MAG)/sulfated glucuronyl paragloboside (SGPG) neuropathy associated with Waldenström macroglobulinemia show demyelinating neuropathy, but the temporal dispersion of distal compound muscle action ...
Kanji Yamamoto
doaj +1 more source
Waldenstrom\u27s macroglobulinemia terminating in acute myeloid leukemia
, 2006 Waldenstrom\u27s macroglobulinemia (WM) is a rare condition, accounting for approximately 2% of haematologic malignancies. The most common causes of death in these patients are progression of the malignant lymphoproliferative process, infection and ...
Adil, Salman +2 more
core
Waldenstrom Macroglobulinemia Recurrence with Bing–Neel Syndrome Presentation
Bing–Neel syndrome (BNS) is a rare condition that may occur in patients with Waldenstrom macroglobulinemia (WM) and is caused by lymphoplasmacytic infiltration into the central nervous system.
Raffaella Capasso +3 more
core +1 more source
Clonal evolution in Waldenstrom macroglobulinemia highlights functional role of B-cell receptor
, 2001 The course of clonal evolution of 2 related clones in the blood of a patient with Waldenstrom macroglobulinemia (WM) indicates the functional importance for the expression of the B-cell receptor for the survival of these malignant cells.
Robert A. Kyle +5 more
core +1 more source